Clinical Research Site #320 — Shelby, Michigan

Clinical Research Site #320 is a clinical research site located in Shelby, Michigan, United States 48315.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Research Site #320 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Immunoglobulin A Nephropathy.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Shelby

Browse all research sites in Michigan · View every site in Shelby

• Henry Ford Macomb Health Center - Shelby Township
• St. Clair Nephrology Research
• Clinical Trial Site
• St. Clair Nephrology
• Medical Practice
• ADARx Clinical Site
• Site-015
• St. Clair Nephrology /ID# 271445
• St. Clair Nephrology Research, LLC - Shelby Township
• Alliance Health Shelby Family Medicine
• Osteopathic Medical Oncology Hematology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Research Site #320?

Clinical Research Site #320 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Research Site #320 conducted?

Clinical Research Site #320 has 1 clinical trials on record, with 1 currently active. Their work covers Immunoglobulin A Nephropathy.

Is Clinical Research Site #320 accredited by Crixeo Clinical Trials?

Clinical Research Site #320 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Research Site #320?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.